SERPIN PHARMA LLC has a total of 27 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are CUREDM GROUP HOLDINGS LLC, NEURONAX and GEMMA BIOTECHNOLOGY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 4 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Brazil | 2 | |
#7 | China | 2 | |
#8 | Hong Kong | 2 | |
#9 | Israel | 2 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Gelber Cohava | 22 |
#2 | Mogelsvang Soren | 14 |
#3 | Cohava Gelber | 3 |
#4 | Soren Mogelsvang | 2 |
Publication | Filing date | Title |
---|---|---|
AU2016317726A1 | Methods for treatment of diseases | |
WO2014197524A2 | Peptide therapy for treatment of alpha-1 antitrypsin deficiency and associated pathologies | |
EP3381461A1 | Peptides and methods of using same |